Influence of Coagulation Factor X on In Vitro and In Vivo Gene Delivery by Adenovirus (Ad) 5, Ad35, and Chimeric Ad5/Ad35 Vectors

Overview of attention for article published in Molecular Therapy, July 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 1 X user

patent: 6 patents

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Dosing regime and formulations for type B adenoviruses

Grant US-12350302-B2

United States of America

08 Jul 2025

Dosing regime and formulations for type B adenovirus

Grant US-11173186-B2

United States of America

16 Nov 2021

A DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES

Application EP-3777870-A1

European Patent Office

17 Feb 2021

Recombinant adenovirus vector and construction method and application thereof

Grant CN-106868047-B

China

28 Apr 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.